Genomatica licenses its GENO BDO biomanufacturing process technology to Cargill, which is using it in its newly-announced joint venture with HELM, Qore, to produce renewable 1,4-butanediol (BDO). The technology will be a part of the recently announced $300M investment by Cargill and HELM at the biotechnology campus in Eddyville, Iowa. With the completion of this facility in 2024, Genomatica’s technology will reportedly enable a combined, global production capacity of over 100,000 tons per year of renewable BDO.
Under a single plant license, Genomatica provides the latest generation of its proprietary GENO BDO process along with a complete process design package and technology services, receiving license fees and royalties in exchange. In addition to the Novamont facility in Bottrighe, Italy, this project represents the second large-scale commercial plant set to be powered by Genomatica’s technology, according to the company.
“Innovations and creative partnerships are essential for the realization of new and improved value chains to meet the ever-rising demand for more sustainable solutions that consumers, brands and our planet need,” says Christophe Schilling, Genomatica CEO.
“Sustainable chemicals are quickly becoming table stakes for our customers and our investments will enable the chemicals industry to embrace new markets with the materials consumers are demanding from companies they trust,” says Jill Zullo, vice president, biointermediates/bioindustrial at Cargill.
For more information, visit www.genomatica.com
